Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice.

    Tschen SI, Dhawan S, Gurlo T, Bhushan A.

    Diabetes. 2009 Jun;58(6):1312-20. Epub 2009 Feb 19.PMID: 19228811 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adaptive beta-cell proliferation is severely restricted with advanced age.

    Rankin MM, Kushner JA.

    Diabetes. 2009 Jun;58(6):1365-72. Epub 2009 Mar 5.PMID: 19265026 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus.

    Chen H, Gu X, Su IH, Bottino R, Contreras JL, Tarakhovsky A, Kim SK.

    Genes Dev. 2009 Apr 15;23(8):975-85.PMID: 19390090 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Exendin-4 stimulation of cyclin A2 in beta-cell proliferation.

    Song WJ, Schreiber WE, Zhong E, Liu FF, Kornfeld BD, Wondisford FE, Hussain MA.

    Diabetes. 2008 Sep;57(9):2371-81. Epub 2008 Jun 10.PMID: 18544709 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation.

    Dhawan S, Tschen SI, Bhushan A.

    Genes Dev. 2009 Apr 15;23(8):906-11.PMID: 19390085 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14.

    Klinger S, Poussin C, Debril MB, Dolci W, Halban PA, Thorens B.

    Diabetes. 2008 Mar;57(3):584-93. Epub 2007 Nov 19.PMID: 18025410 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Exendin-4 modulates diabetes onset in nonobese diabetic mice.

    Hadjiyanni I, Baggio LL, Poussier P, Drucker DJ.

    Endocrinology. 2008 Mar;149(3):1338-49. Epub 2007 Dec 6.PMID: 18063685 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.

    Juang JH, Kuo CH, Wu CH, Juang C.

    Cell Transplant. 2008;17(6):641-7.PMID: 18819252 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.

    Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.

    J Biol Chem. 2003 Jan 3;278(1):471-8. Epub 2002 Oct 29.PMID: 12409292 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice.

    Agudo J, Ayuso E, Jimenez V, Salavert A, Casellas A, Tafuro S, Haurigot V, Ruberte J, Segovia JC, Bueren J, Bosch F.

    Diabetologia. 2008 Oct;51(10):1862-72. Epub 2008 Jul 29.PMID: 18663428 [PubMed - indexed for MEDLINE]Related articles

    12.

    Exendin-4 does not promote Beta-cell proliferation or survival during the early post-islet transplant period in mice.

    Crutchlow MF, Yu M, Bae YS, Deng S, Stoffers DA.

    Transplant Proc. 2008 Jun;40(5):1650-7. Erratum in: Transplant Proc. 2009 Jan-Feb;41(1):450. PMID: 18589167 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.
    14.

    Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

    Xu G, Stoffers DA, Habener JF, Bonner-Weir S.

    Diabetes. 1999 Dec;48(12):2270-6.PMID: 10580413 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glucagon-like peptide-1.

    Doyle ME, Egan JM.

    Recent Prog Horm Res. 2001;56:377-99. Review.PMID: 11237222 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.

    Liu MJ, Shin S, Li N, Shigihara T, Lee YS, Yoon JW, Jun HS.

    Mol Ther. 2007 Jan;15(1):86-93.PMID: 17164779 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.

    Jang SM, Yee ST, Choi J, Choi MS, Do GM, Jeon SM, Yeo J, Kim MJ, Seo KI, Lee MK.

    Int Immunopharmacol. 2009 Jan;9(1):113-9. Epub 2008 Nov 20.PMID: 19013541 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin.

    Thyssen S, Arany E, Hill DJ.

    Endocrinology. 2006 May;147(5):2346-56. Epub 2006 Feb 16.PMID: 16484329 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.

    Bruggeman SW, Valk-Lingbeek ME, van der Stoop PP, Jacobs JJ, Kieboom K, Tanger E, Hulsman D, Leung C, Arsenijevic Y, Marino S, van Lohuizen M.

    Genes Dev. 2005 Jun 15;19(12):1438-43.PMID: 15964995 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    beta-cell failure in diabetes and preservation by clinical treatment.

    Wajchenberg BL.

    Endocr Rev. 2007 Apr;28(2):187-218. Epub 2007 Mar 12. Review.PMID: 17353295 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data